| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 26.49B | 24.22B | 21.33B | 19.66B | 18.31B |
| Gross Profit | 10.12B | 8.02B | 5.63B | 4.89B | 4.91B |
| EBITDA | 4.70B | 3.18B | 1.69B | 1.12B | 1.40B |
| Net Income | 2.93B | 1.96B | 744.40M | 320.39M | 646.92M |
Balance Sheet | |||||
| Total Assets | 27.74B | 25.57B | 22.54B | 21.52B | 20.61B |
| Cash, Cash Equivalents and Short-Term Investments | 10.84B | 8.12B | 7.37B | 7.64B | 6.68B |
| Total Debt | 1.02B | 1.13B | 1.06B | 945.98M | 1.08B |
| Total Liabilities | 7.42B | 7.82B | 6.50B | 6.15B | 5.33B |
| Stockholders Equity | 20.32B | 17.74B | 16.04B | 15.36B | 15.28B |
Cash Flow | |||||
| Free Cash Flow | 4.21B | 1.22B | -39.16M | 1.43B | -2.35B |
| Operating Cash Flow | 5.06B | 1.54B | 166.88M | 1.71B | -988.75M |
| Investing Cash Flow | -1.28B | -564.11M | -297.13M | -356.27M | -1.32B |
| Financing Cash Flow | -1.07B | -226.11M | -138.66M | -392.44M | -141.48M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥65.90B | 7.90 | ― | 3.95% | 2.75% | 25.75% | |
80 Outperform | ¥73.11B | 12.40 | ― | 2.63% | 2.11% | 0.91% | |
77 Outperform | ¥72.29B | 11.84 | ― | 2.79% | 4.22% | 7.91% | |
75 Outperform | ¥36.37B | 9.55 | ― | 2.74% | 9.38% | 49.37% | |
74 Outperform | ¥41.02B | 10.49 | ― | 3.95% | -4.76% | 20.37% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥72.43B | 13.34 | ― | 3.09% | 7.43% | 47.68% |